AIMLF.US AI/ML Innovations Inc
- Market cap
- USD 8.65M
- P/E
- -
- P/B
- 42.50x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jul 2026.
Is AIMLF.US undervalued?
Graham numberThe Graham number of AI/ML Innovations Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
AI/ML Innovations Inc fundamental analysis
No fundamental analysis for AI/ML Innovations Inc yet.
AI/ML Innovations Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About AI/ML Innovations Inc
AI/ML Innovations Inc. operates in the digital healthcare business using artificial intelligence (AI) and machine learning (ML) in Canada. The company offers The Neural Cloud, a signal processing neural network designed to extract true signals from the noisiest recordings; Cardio Yield, an ECG reporting software, built to automate event labeling, interval calculation, and rhythm classification; and Insight 360 that transforms raw ECG data into clear, actionable insights thro…
Full company profileAI/ML Innovations Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jul 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
AI/ML Innovations Inc annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | - | 0.00 | 0.00 | 0.00 | 0.00 | 65.4K | 488K | 600K | 167K | 83.1K | 8.00K |
| Gross Profit | - | - | - | - | - | 65.4K | 466K | 295K | 163K | 81.1K | 8.00K |
| Operating Income | - | -96.5K | -98.5K | -176K | -1.43M | -3.35M | -1.35M | -1.62M | -4.84M | -6.49M | -7.00M |
| EBITDA | - | -86.9K | -129K | -177K | -2.79M | -3.44M | -1.39M | -3.20M | -4.54M | -6.21M | -6.93M |
| Net Income | - | -124K | -167K | -216K | -2.73M | -3.17M | -1.42M | -3.28M | -4.59M | -6.36M | -7.40M |
| EPS | - | -0.02 | -0.02 | -0.02 | -0.09 | -0.09 | -0.03 | -0.04 | -0.02 | -0.02 | -0.03 |
| Balance Sheet | |||||||||||
| Total Assets | - | 161K | 157K | 320K | 3.59M | 2.04M | 1.51M | 330K | 3.41M | 2.07M | 2.02M |
| Total Liabilities | - | 1.93M | 2.09M | 2.14M | 1.51M | 1.55M | 1.79M | 1.54M | 856K | 2.89M | 4.10M |
| Shareholders' Equity | - | -1.77M | -1.93M | -1.82M | 2.09M | 489K | -280K | -1.17M | 2.60M | -785K | -2.04M |
| Cash & Short-term Investments | - | 30.9K | 3.82K | 138K | 3.37M | 475K | 4.53K | 201K | 1.99M | 251K | 276K |
| Cash Flow | |||||||||||
| Operating Cash Flow | -22.0K | -37.1K | -7.15K | -127K | -931K | -3.02M | -634K | -1.64M | -3.99M | -5.41M | -4.88M |
| Capital Expenditure | 14.4K | 18.8K | 19.9K | 27.8K | 27.7K | 0.00 | 0.00 | 0.00 | 1.15K | 4.67K | 4.13K |
| Free Cash Flow | - | -37.1K | -7.15K | -127K | -931K | -3.02M | -648K | -1.64M | -3.99M | -5.41M | -4.88M |
| Ratios | |||||||||||
| ROE | - | - | - | - | -130.5% | -649.2% | - | - | -176.9% | - | - |
| ROA | - | -76.9% | -106.4% | -67.4% | -75.8% | -155.6% | -94.3% | -996.4% | -134.5% | -307.8% | -366.7% |
| Net Profit Margin | - | - | - | - | - | -4,851.5% | -291.7% | -547.4% | -2,745.0% | -7,652.0% | -92,481.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
AI/ML Innovations Inc dividends
AI/ML Innovations Inc has not paid dividends in the last 9 fiscal years.
Last stock split: 1:10 on Feb 12, 2020.
Who owns AI/ML Innovations Inc
- Insiders 21.75%
- Institutions 0.00%
- Public & others 78.25%
- Shares outstanding 298M
- Free float 208M
AI/ML Innovations Inc company profile
- Company name
- AI/ML Innovations Inc
- Ticker
- AIMLF.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Technology
- Fiscal year end
- April
- Address
- Pacific Centre, Vancouver, BC, Canada, V7Y 1B3
- Phone
- 416 941 8900
- Website
- aiml-innovations.com
About AI/ML Innovations Inc
AI/ML Innovations Inc. operates in the digital healthcare business using artificial intelligence (AI) and machine learning (ML) in Canada. The company offers The Neural Cloud, a signal processing neural network designed to extract true signals from the noisiest recordings; Cardio Yield, an ECG reporting software, built to automate event labeling, interval calculation, and rhythm classification; and Insight 360 that transforms raw ECG data into clear, actionable insights through advanced visualization, analytics, and customizable reporting tools. It also engages in the research and development of health and wearable technologies; and sale of licenses and consulting services related to the company's technologies. The company was formerly known as AIML Resources Inc. and changed its name to AI/ML Innovations Inc. in November 2020. AI/ML Innovations Inc. is based in Vancouver, Canada.
AI/ML Innovations Inc management
8- Mr. John Paul DuffyPresident, CEO & Executive Chairman · born 1966
- Mr. Esmat NaikyarChief Product Officer & President of Neural Cloud
- Mr. Lynn Chapman C.A., C.P.A.Chief Financial Officer
- Mr. Erik SuokasCOO, AIML & Neural Cloud
- Dr. Alan Rabinowitz FACC, FRCPCChief Medical Officer, Member of Medical Advisory Board & Director of Medical Partnerships
- Ms. Andrea L. Ruth M.S.Head of Quality, Clinical, & Regulatory
- Dr. Mehmet A. Kosoglu Ph.D.Head of Regulatory for NeuralCloud Solutions Inc.
- Ms. Kendra Low BHK, M.B.A.Company Secretary · born 1980